Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
Medable has raised $304.0M in total funding. The most recent round was Series D. The last funding was announced in October 2021.
Medable's investors include Sapphire Ventures, Obvious Ventures, GSR Ventures, HealthX Ventures, Western Technology Investment.
Medable is headquartered in Palo Alto, United States.
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
Medable is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medable — Funding & Investors." VCBacked, October 26, 2021, https://www.vcbacked.co/company/medable. Accessed September 29, 2026.
VCBacked. (2021). Medable — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/medable
{{cite web |title=Medable — Funding & Investors |url=https://www.vcbacked.co/company/medable |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated